Aminophenazone/Phenacetin/Caffeine/Phenobarbital

氨基比林/非那西丁/咖啡因/苯巴比妥

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAminophenazone/Phenacetin/Caffeine/Phenobarbital
Drug Alias NameCompound Aminopyine Tablets去痛片Tabellae Aminophenazoniet Phenacetini Compositae
ClassificationSmall molecules
Mechanisms of ActionAdenosine A1 receptor antagonistsAdenosine A2a receptor antagonistsGamma-aminobutyric acid A receptor agonists
TargetsAdenosine A1 receptorAdenosine A2a receptorGamma-aminobutyric acid A receptor
Therapy Area/IndicationsMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes AminophenazonePhenacetinCaffeine
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsMigraine Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A